Neil J Shimwell
Overview
Explore the profile of Neil J Shimwell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
86
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chalabi Hagkarim N, Ryan E, Byrd P, Hollingworth R, Shimwell N, Agathanggelou A, et al.
J Virol
. 2018 Mar;
92(12).
PMID: 29593045
Infection by most DNA viruses activates a cellular DNA damage response (DDR), which may be to the detriment or advantage of the virus. In the case of adenoviruses, they neutralize...
2.
Qi Y, Ward D, Pang C, Wang Q, Wei W, Ma J, et al.
Proteomics
. 2013 Nov;
14(2-3):186-95.
PMID: 24259486
The aim of this study was to identify novel biomarkers for the diagnosis of, and potential therapeutic targets for, hepatocellular carcinoma (HCC). Multilectin affinity chromatography was used to enrich N-linked...
3.
Probing the complementarity of FAIMS and strong cation exchange chromatography in shotgun proteomics
Creese A, Shimwell N, Larkins K, Heath J, Cooper H
J Am Soc Mass Spectrom
. 2013 Feb;
24(3):431-43.
PMID: 23400772
High field asymmetric waveform ion mobility spectrometry (FAIMS), also known as differential ion mobility spectrometry, coupled with liquid chromatography tandem mass spectrometry (LC-MS/MS) offers benefits for the analysis of complex...
4.
Forrester N, Patel R, Speiseder T, Groitl P, Sedgwick G, Shimwell N, et al.
J Virol
. 2011 Dec;
86(6):3167-79.
PMID: 22205733
The ability of adenovirus early region proteins, E1B-55K and E4orf6, to usurp control of cellular ubiquitin ligases and target proteins for proteasome-dependent degradation during infection is well established. Here we...
5.
Bryan R, Wei W, Shimwell N, Collins S, Hussain S, Billingham L, et al.
Proteomics Clin Appl
. 2011 Aug;
5(9-10):493-503.
PMID: 21805675
Purpose: There is a need for better biomarkers to both detect bladder cancer and distinguish muscle-invasive (stage T2+) from non-invasive (stage Ta/T1) disease. We assess whether MALDI-TOF-MS of the urine...
6.
Shimwell N, Wei W, Wilson S, Wakelam M, Ismail T, Iqbal T, et al.
Cancer Biomark
. 2011 Jan;
7(3):123-32.
PMID: 21263188
Background: Patients with colorectal cancer often present with advanced disease and concomitant poor prognosis. The best known serum biomarker, carcinoembryonic antigen (CEA) is not recommended for screening because of its...